Growth Metrics

Medinotec (MDNC) Long-Term Debt Repayments (2024 - 2025)

Medinotec posted quarterly Long-Term Debt Repayments of $2531.0 for Q4 2025, down 97.69% year-on-year from $109684.0 in Q4 2024, and down 99.75% on a QoQ basis from $1.0 million in Q3 2025.

Medinotec (MDNC) has 2 years of Long-Term Debt Repayments data on file, last reported at $2531.0 in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Repayments fell 97.69% year-over-year to $2531.0; the trailing twelve-month figure through Nov 2025 stood at -$755836.0 (down 167.7% YoY), and the FY2025 full-year result was -$895279.0, down 9148.75% from the prior year.
  • Long-Term Debt Repayments for Q4 2025 stood at $2531.0, down from $1.0 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $1.3 million in Q3 2024 and bottomed at -$1.7 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Medinotec - - 854,557.00 -

Historic Data

Download Data 🔒
DateValue
Nov 30, 2025 2,531.00
Nov 30, 2025 2,531.00
Aug 31, 2025 1.02 Mn
Aug 31, 2025 1.02 Mn
May 31, 2025 -37,900.00
May 31, 2025 -37,900.00
Feb 28, 2025 -1.74 Mn
Feb 28, 2025 -1.74 Mn
Nov 30, 2024 109,684.00
Nov 30, 2024 109,684.00
Aug 31, 2024 1.28 Mn
Aug 31, 2024 1.28 Mn
May 31, 2024 -541,541.00
May 31, 2024 -541,541.00
Feb 29, 2024 272,872.00
Feb 29, 2024 272,872.00